Loading company
Loading
Latest quarter · Q1 FY2019
Millions- Total revenues
- 4
- Operating income
- (7)
- Net income
- (7)
Arcturus Therapeutics Ltd. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2018 | FY2017 | Change | Source |
|---|---|---|---|---|
| Total assets | $44.2 million | $52 million | -15% | 10-K 2019-03-18 · proof |
| Total liabilities | $30.6 million | $18.2 million | +67.6% | 10-K 2019-03-18 · proof |
| Cash and cash equivalents | $36.7 million | $25 million | +47% | 10-K 2019-03-18 · proof |
- What are Arcturus Therapeutics Ltd.'s total assets?
- As of Dec 31, 2018, Arcturus Therapeutics Ltd. reported total assets of $44.2 million, against $52 million a year earlier (-15%). Source: the 10-K filed with the SEC on Mar 18, 2019. SEC
- What are Arcturus Therapeutics Ltd.'s total liabilities?
- As of Dec 31, 2018, Arcturus Therapeutics Ltd. reported total liabilities of $30.6 million, against $18.2 million a year earlier (+67.6%). Source: the 10-K filed with the SEC on Mar 18, 2019. SEC
- What are Arcturus Therapeutics Ltd.'s cash and cash equivalents?
- As of Dec 31, 2018, Arcturus Therapeutics Ltd. reported cash and cash equivalents of $36.7 million, against $25 million a year earlier (+47%). Source: the 10-K filed with the SEC on Mar 18, 2019. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1566049&period_type=annual&limit=5"Information only, not investment advice.